Behavioral Pain Self-Management Intervention Effective for Chronic Pain With HIV
By Lori Solomon HealthDay Reporter
WEDNESDAY, July 24, 2024 -- A behavioral pain self-management intervention is effective for chronic pain in people living with HIV, according to a study published online July 15 in JAMA Internal Medicine.
Katie Fitzgerald Jones, Ph.D., from the VA Boston Healthcare System, and colleagues evaluated the efficacy of a behavioral pain self-management intervention called Skills to Manage Pain (STOMP) among 278 adults with HIV who experienced at least moderate chronic pain for three or more months versus enhanced usual care (EUC).
The researchers found that of the six possible one-on-one sessions, participants attended a mean of 2.9 sessions and for the six possible group sessions, participants attended a mean of 2.4 sessions. Compared to EUC, STOMP was associated with a statistically significant mean difference for the primary outcome, Brief Pain Inventory (BPI) total score (−1.25 points) immediately after the intervention. The mean difference in BPI total score remained statistically significant three months after the intervention, favoring the STOMP intervention (−0.62 points).
"The STOMP intervention also has the potential to be tailored to other highly affected groups including cancer survivors, older adults, or veterans who frequently experience chronic multisite pain," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
FDA Approves Twice-Yearly Yeztugo for Preexposure Prophylaxis to Cut HIV Risk
FRIDAY, June 20, 2025 -- The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to...
Anal Cancer Screening Cost-Effective for HIV+ Men Who Have Sex With Men ≥35 Years of Age
TUESDAY, June 17, 2025 -- For men who have sex with men (MSM) with HIV, aged 35 years or older, anal cancer screening is cost-effective, according to a study published online June...
Initiation of HIV PrEP in Young Adults Rose in Recent Years
TUESDAY, June 3, 2025 -- Dispensing and initiation of HIV preexposure prophylaxis (PrEP) among young adults increased from 2016 through 2023, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.